Here, we compared the mRNA and protein levels of TET1, TET2, and TET3 in non-diabetic (ND) control subjects, patients with only type 2 diabetes only (D), and patients with diabetes peripheral artery disease (D-PAD). This evidence concerns the gene TET1 and type 2 diabetes mellitus.